Opinion statement
Chronic diarrhea can be due to any of several hundred conditions. When investigation fails to uncover a specific cause that can be treated successfully, nonspecific therapy is implemented. This includes dietary alterations if specific aggravating foods can be identified, enteral or parenteral nutrition if nutritional status is compromised, and use of oral rehydration solutions if diarrhea produces volume depletion. Strategic use of dietary fiber can improve stool consistency and can be of special value when fecal incontinence is present concurrently. Medications of value include opiate antidiarrheal drugs, clonidine, octreotide, and bile acid-binding agents. Less potent opiates such as loperamide and diphenoxylate should be tried first, with more potent agents such as codeine, opium, and morphine used in refractory cases. Clonidine has both proabsorptive and motility effects that facilitate its antidiarrheal effect, but its antihypertensive action limits its utility. Octreotide is of great value in treating diarrhea due to endocrine tumors and dumping syndrome; its efficacy in other conditions or in nonspecific diarrhea is less well established. Bile acid binders such as cholestyramine or colestipol have several specific uses but have limited utility in nonspecific chronic diarrhea.
Similar content being viewed by others
References and Recommended Reading
Schiller LR: Review article: anti-diarrhoeal pharmacology and therapeutics. Aliment Pharmacol Ther 1995, 9: 87–106. An older, but still current review of available agents and mechanisms that is well referenced.
Eherer AJ, Santa Ana CA, Porter J, Fordtran JS: Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein. Gastroenterology 1993, 104: 1007–1012.
Bliss DZ, Jung HJ, Savik K, et al.: Supplementation with dietary fiber improves fecal incontinence. Nurs Res 2001, 50: 203–213.
Rabbani GH, Teka T, Saha SK, Zaman B, Majid N, Khatun M, Wahed MA, Fuchs GJ: Green bananas and pectin improve small intestinal permeability and reduce fluid loss in Bangladeshi children with persistent diarrhea. Dig Dis Sci 2004, 49: 475–484. A recent study that suggests that pectin may do more than just change stool consistency by effects on intestinal permeability.
Wingate D, Phillips SF, Lewis SJ, et al.: Guidelines for adults on self-medication for the treatment of acute diarrhea. Aliment Pharmacol Ther 2001, 15: 773–782.
Camilleri M, Kim DY, McKinzie S, et al.: A randomized, controlled exploratory study of clonidine in diarrheapredominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2003, 1: 111–121.
Szilagyi A, Shrier I: Systematic review: the use of somatostatin or octreotide in refractory diarrhoea. Aliment Pharmacol Ther 2001, 15: 1889–1897. A careful analysis of published reports about the use of sandostatin and octreotide in refractory diarrhea that suggests that these agents may be of some use, but that the evidence of benefit is not firm.
Benson AB 3rd, Ajani JA, Catalano RB, et al.: Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004, 22: 2918–2926.
Garcia Compean D, Ramos Jimenez J, et al.: Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial. AIDS 1994, 8: 1563–1567.
Zaid MR, Hasan M, Khan AA: Attapulgite in the treatment of acute diarrhoea: a double-blind placebocontrolled study. J Diarrhoeal Dis Res 1995, 13: 44–46.
Rao G, Aliwalas MG, Slaymaker E, Brown B: Bismuth revisited: an effective way to prevent travelers’ diarrhea. J Travel Med 2004, 11: 239–241.
Wildt S, Norby Rasmussen S, Lysgard Madsen J, Rumessen JJ: Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test. Scand J Gastroenterol 2003, 38: 826–830.
Farthing MJ: Novel targets for the control of secretory diarrhoea. Gut 2002, 50(Suppl 3):15–18.
Matheson AJ, Noble S: Racecadotril. Drugs 2000, 59: 829–835.
Huighebaert S, Awouters F, Tytgat GN: Racecadotril versus loperamide: antidiarrheal research revisited. Dig Dis Sci 2003, 48: 239–250.
Thiagarajah JR, Verkman AS: CFTR pharmacology and its role in intestinal fluid secretion. Curr Opin Pharmacol 2003, 3: 594–599.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schiller, L.R. Chronic diarrhea. Curr Treat Options Gastro 8, 259–266 (2005). https://doi.org/10.1007/s11938-005-0018-8
Issue Date:
DOI: https://doi.org/10.1007/s11938-005-0018-8